Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.
- Published In:
- The international journal of neuropsychopharmacology, 23(9), 581-586 (2020)
- Authors:
- Alvarez, X Anton, Alvarez, Irene, Martinez, Antia, Romero, Iria, Benito, Concha, Suarez, Irene, Mourente, Silvia, Fantini, Manuel, Figueroa, Jesús, Aleixandre, Manuel, Linares, Carlos, Muresanu, Dafin, Winter, Stefan, Moessler, Herbert
- Database ID:
- RPEP-04632
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04632APA
Alvarez, X Anton; Alvarez, Irene; Martinez, Antia; Romero, Iria; Benito, Concha; Suarez, Irene; Mourente, Silvia; Fantini, Manuel; Figueroa, Jesús; Aleixandre, Manuel; Linares, Carlos; Muresanu, Dafin; Winter, Stefan; Moessler, Herbert. (2020). Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.. The international journal of neuropsychopharmacology, 23(9), 581-586. https://doi.org/10.1093/ijnp/pyaa046
MLA
Alvarez, X Anton, et al. "Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.." The international journal of neuropsychopharmacology, 2020. https://doi.org/10.1093/ijnp/pyaa046
RethinkPeptides
RethinkPeptides Research Database. "Serum VEGF Predicts Clinical Improvement Induced by Cerebrol..." RPEP-04632. Retrieved from https://rethinkpeptides.com/research/alvarez-2020-serum-vegf-predicts-clinical
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.